RDIF, Panacea Biotec to start Sputnik V production in India
New Delhi | Production of the Sputnik V vaccine against coronavirus will begin in India this summer, the Russian Direct Investment...
Sputnik V
1st Sputnik dose given in Hyderabad, priced at Rs 948+GST
New Delhi | Dr Reddy's Laboratories on Friday announced that the first consignment of imported doses of the Sputnik V vaccine...
Russia’s Sputnik V Covid vax to be available in market from next week: Govt
New Delhi | The Union Health Ministry on Thursday announced that Russia's Sputnik V, the vaccine against the Covid-19 pandemic, will...
RDIF sets target of 50m doses a month for Sputnik in India
New Delhi/Moscow | More than 50 million doses of Sputnik V vaccine will be produced in India in a month over...
India permits use of Sputnik-V vaccine in emergency situations
New Delhi | After Covishield and Covaxin, India on Tuesday granted permission to inject the third Covid-19 vaccine 'Gam-COVID-Vac' combined vector...
Yet to receive SEC communication on Sputnik V approval: DRL
Hyderabad | Amid reports that the subject expert committee (SEC) has approved Dr. Reddy's Laboratories' (DRL) application for the Russian vaccine...
RDIF awaiting SEC recommendation for Sputnik approval in India
New Delhi | The Russian Direct Investment Fund said on Monday it is "awaiting imminently" the recommendation by the Subject Expert...
Sputnik V vaccine shows 91.6% efficacy in phase 3 trials: Lancet
Moscow: Russia's Sputnik V vaccine demonstrated efficacy of 91.6 per cent against Covid-19, according to interim results of phase 3 trials...
India to produce 300mn doses of Sputnik V vaccine in 2021: Report
Moscow: India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, the head of the...
Sputnik V Covid vax likely to offer 2-year protection: Developers
Moscow: Russia's Sputnik V vaccine is likely to offer two-year-long protection against Covid-19, Alexander Gintsburg, the head of the vaccine's developer,...
